Health TrialsbyHealthPanel

Evaluating Metabolic Health in People Aged 18 to 60 by Nutrilite Metabolic Health Index

ConditionsMetabolic AbnormalityMetabolic Disorders
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-60
SponsorAmway (China) R&D Center

About this trial

The goal of this observational study is to evaluate Metabolic Health by fit analysis between calculated Nutrilite Metabolic Health Index and the result of Metabolomics analysis from blood plasma samples in healthy adult participants aged between 18 and 60 years. The main question it aims to answer:

\- Does the Nutrilite Metabolic Health Index fit well with the result of Metabolomics analysis from blood plasma samples?

200 eligible participants will be enrolled in a single center, one site visit will be made to finish a health questionnaire, a lifestyle questionnaire, a routine physical checkup. Blood samples will be collected for routine blood test (blood sugar, total triglycerides, total cholesterol, low-density lipoprotein cholesterol, high-density lipoprotein cholesterol, uric acid), and for Metabolomics testing.

Researchers will calculate the Nutrilite Metabolic Health Index based on participant data, and do the fit analysis against the result from Metabolomics analysis.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Male and female volunteers, aged 18 to 60, regardless of gender;

Not participating in other interventional clinical studies;

Have a good understanding of the nature, purpose, benefits obtained, and possible risks and side effects of the study;

Willing to comply with all trial requirements and procedures;

Disqualifiers

In the treatment of gastrointestinal symptoms;

Those who are lactose intolerant, allergic to fish and their products;

Current suffering from other organic diseases affecting bowel function, such as history of gastrointestinal resection, colon or rectal cancer, inflammatory bowel disease, diabetes, hyperthyroidism or hypothyroidism, Hirschsprung's disease, scleroderma, anorexia nervosa, etc.;

Diet control, exercise enhancement, or taking medications that control weight or affect appetite in the past 3 months;

Trial population

Male and female participants, aged 18 to 60, regardless of gender;

Trial design

Design model

Other

Time perspective

Cross-sectional

Treatments tested in this trial

  • No Intervention: Observational Cohort

    Other intervention

    No intervention involved, participants will fill out some questionnaires and blood samples will drawn for test and analysis.

Treatment groups

200 Participants
are divided into 1 treatment group
Group A: All participants1 intervention

Trial outcomes

Primary outcomes

1

Nutrilite Metabolic Health Index

Nutrilite Metabolic Health Index incorporates seven core biochemical parameters (see details in Secondary Outcome Measures): body mass index (BMI), waist circumference, fasting blood glucose (FBG) level, blood lipid profile (total cholesterol (TC), total triglycerides(TG), Low-Density Lipoprotein Cholesterol (LDL), High-Density Lipoprotein Cholesterol (HDL), blood pressure (Systolic Blood Pressure(SBP), and Diastolic Blood Pressure (BDP)), uric acid level, and history of fatty liver disease; along with four lifestyle and hereditary factors: smoking, alcohol consumption, age, and family history of metabolic diseases. After weighted calculation, the index score ranges from 0 to 100, divided into four grades: Excellent: 85-100 Moderate: 60-84 Poor: 40-59 Severe: 0-39

Time frame
day 1

Secondary outcomes

1

SBP

SBP(Systolic Blood Pressure), ideally \<120 mmHg or still normal if less than 130mmHg

Time frame
day 1
2

DBP

BDP(Diastolic Blood Pressure), ideally \<80 mmHg, or still normal if less than 89 mmHg

Time frame
day 1
3

Blood test - LDL-C

LDL-C(Low-Density Lipoprotein Cholesterol) concentration level in the blood sample test: normal range 0-3.1mmol/L, higher than 3.1 mmol/L is abnormal;

Time frame
day 1
4

Blood test - HDL-C

HDL-C(High-Density Lipoprotein Cholesterol) concentration level in the blood sample test: normal range 1.04\~1.55 mmol/L, lower than 1.04 or higher than 1.55 mmol/L is abnormal;

Time frame
day 1

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Amway (China) R&D Center

Lead sponsor

Source ClinicalTrials.gov

This trial is not recruiting at the moment. You can still explore other options: